Alzheimer's and Dementia Conference

Dear colleagues, the upcoming congress will be an opportunity to come together and share ideas for initiating progress in age-related diseases. Alzheimer’s disease is a plague of our times. Hardly any other disease comes with such a burden for the afflicted individual, the proxies, and the healthcare system. While therapies targeting the pathophysiological processes with monoclonal antibodies are expensive, it will be much more expensive for societies to set these therapies aside and rely on nursing care. For ethical reasons therapies need to be developed that alleviate symptoms of this disease and help to maintain the capacity and personality of patients. Assessment of change over the course disease, however, still uses methods deployed decades ago. It is time to rethink the diagnostic process and the assessment of therapeutic efficacy. New assessment strategies will be the key to improving patients autonomy, alleviating the burden for proxies and increasing healthcare efficiency.

2nd International Alzheimer’s Disease & Dementia Conference | June 16-17, 2023 | Hybrid Event

Dear congress visitors, it is an honor and pleasure to welcome you to Dementia 2023. Dementia is a devastating neurodegenerative condition. Though medications can alleviate some symptoms of dementia, the lack of robust biomarkers to facilitate early diagnosis means that current interventions are typically given too late to modify disease progression. Thus, accurate and timely diagnosis is key for optimal intervention. Dementia related changes likely occur decades before symptoms are observed underscoring the need for novel tools that can aid in the early identification. A better understanding of the early changes in the brain in Dementia and their relation to cognitive function using advanced imaging methods will ultimately facilitate the development of measures for early detection and progression of dementia.

2nd International Alzheimer’s Disease & Dementia Conference | Hybrid Event | June 16-17, 2023

Dear congress visitors, I am honored to write a few words of welcome. Artificial intelligence is currently being applied to various fields such as autonomous driving, face recognition, and voice recognition systems. It is also widely applied in the medical field, such as support for image diagnosis, and estimation of health conditions based on wearable device information. In the future, along with the development of medical data platforms, the application of AI to the dementia field is expected to progress. In this presentation, as an example of the latest clinical application of Al to the field of dementia, I will introduce a new method for estimating cognitive function and brain atrophy from health checkup data. We hope that this lecture will advance the application of Al to the field of dementia.

2nd International Alzheimer’s Disease & Dementia Conference | Rome, Italy | June 16-17, 2023

As the Chair, I am very honorable and pleasurable to write these welcome notes.  

Currently, more than 55 million people have dementia worldwide with that number to triple by 2050. The cost of dementia is?US$ 1.3 trillion?globally and is projected to increase to US$ 2.8 trillion by 2030. There is no cure for this disease, and the current treatments are neither specific nor always effective. Moreover, the molecular mechanisms underlying dementia are not fully understood.  

Without a doubt, the conference, Dementia 2023, will provide a unique and timely fantastic opportunity for delegates, researchers, scientists, physicians, caregivers, and professionals? from all corners of the globe to meet and explore the most recent, energizing, and innovative developments as well as discoveries in every facet of this disease. With the growing prevalence and mortality of dementia, there is an increasing urgent need to develop novel and effective methods for earlier detection of the disease, elucidate the molecular pathogenesis for the initiation and progression of dementia, and generate specific and efficacious drugs and biologics for better treatment of the disease. One can expect that the developments and discoveries presented in this conference will significantly help to solve our aforementioned current urgent challenges.  

2nd International Alzheimer’s Disease & Dementia Conference | June 16-17, 2023 | Rome, Italy

Dear congress visitors, it is an honor and pleasure to invite you to participate to the “2nd International Alzheimer’s Disease & Dementia Conference” (Dementia 2023) that will take place on the 16-17 June 2023, in Hybrid Format in Rome, Italy. During the conference we will explore the latest developments in basic, translational and clinical research related to Alzheimer’s Disease & Dementias. One of the crucial aspects of this congress is the high-level of interdisciplinary exchange between clinicians and basic researchers with the aim to improve the clinical guidelines for diagnosis and treatment of Alzheimer’s Disease & Dementias. We are convinced that to present and discuss each own work with other colleagues, sparking and sharing ideas between scientists, is the key to progress in science. We do encourage you to join us to ask questions and share knowledge during all scientific sessions.

Virtual Event- International Alzheimer’s Disease & Dementia Conference

Dear colleagues, ladies and gentlemen,

It is with a great pleasure to welcome you to the International Alzheimer’s Disease & Dementia Conference 2022. There are over 55 million people worldwide living with dementia (2020), which is now the 7th leading cause of mortality globally (2021), and one of those pathologies with the highest cost to the society. This conference offers excellent opportunity to meet scientists from all over the world and to get insights into the latest developments in the research on the silent epidemic of dementia: to exchange ideas about finding early markers and innovative therapeutic approaches for treatment of Alzheimer’s and Parkinson’s patients. Together we can achieve more!

Wishing you a fruitful meeting and great success in your research

International Alzheimer’s Disease & Dementia Conference

Dear Conference Attendees,

It is with great honor and pleasure that I provide a few welcome words to the Dementia 2002 Conference. Dementia is a general term for loss of memory, language, problem-solving and other thinking abilities that are severe enough to interfere with daily life. Alzheimer's disease (AD) is the most common cause of dementia. New technologies, with gene editing, mRNA vaccines, microbiome and others provide new opportunities for understanding the mechanisms and development of novel therapeutics for dementia and AD.  This conference will provide some important information for the advances in dementia.  Therefore, it is a pleasure and honor to invite you to attend “International Alzheimer’s Disease & Dementia Conference” (Dementia 2022).  This propitious conference is tailored around the theme “Explicating Advancements to Combat the Silent Epidemic of Dementia and Alzheimer.”  We look forward to your presence and interactions to help make the conference successful.  Best wishes.

International Alzheimer’s Disease & Dementia Conference - June 15-16, 2022

Dear Conference Attendee:

It is my great honor and pleasure to write a few welcome notes.

This year’s conference will focus on Dementia, a gradual decline of brain functionalities including memory, language, problem-solving, etc. Alzheimer's is the most common cause of dementia accounting for 60-80% of cases. Dementia is caused by damage to brain cells, which interferes with the ability of brain cells to communicate with each other. Protecting brain cell from damage is a natural way to reduce Dementia or slowing down the progression of Alzheimer’s disease. Novel mechanistic research, new approaches of diagnosis, and recent therapeutic development will be presented and discussed in this year’s conference.

International Alzheimer’s Disease & Dementia Conference- Virtual Event

Dear congress visitors:

As the Chair, I am very honorable and pleasurable to write these welcome notes.

Currently, more than 55 million people have dementia worldwide with that number to triple by 2050. The cost of dementia is US$ 1.3 trillion globally and is projected to increase to US$ 2.8 trillion by 2030. There is no cure for this disease, and the current treatments are neither specific nor always effective. Moreover, the molecular mechanisms underlying dementia are not fully understood.

Without a doubt, the conference, Dementia 2022, will provide a unique and timely fantastic opportunity for delegates, researchers, scientists, physicians, caregivers, and professionals from all corners of the globe to meet and explore the most recent, energizing, and innovative developments as well as discoveries in every facet of this disease. With the growing prevalence and mortality of dementia, there is an increasing urgent need to develop novel and effective methods for earlier detection of the disease, elucidate the molecular pathogenesis for the initiation and progression of dementia, and generate specific and efficacious drugs and biologics for better treatment of the disease. One can expect that the developments and discoveries presented in this conference will significantly help to solve our aforementioned current urgent challenges.

June 15-16, 2022- International Alzheimer’s Disease & Dementia Conference

Dear congress visitors, it is an honor and pleasure to invite you to participate to the “International Alzheimer’s Disease & Dementia Conference” (Dementia 2022) that will take place in June 15-16, 2022. During the conference we will explore the latest developments in basic, translational, and clinical research related to Alzheimer’s Disease and Dementias. One of the crucial aspects of this congress is the high-level of interdisciplinary exchange between clinicians and basic researchers with the aim to improve the clinical guidelines for diagnosis and treatment of neurodegenerative diseases. We are convinced that to present and discuss each own work with other colleagues, sparking and sharing ideas between scientists, is the key to progress in science. We do encourage you to join us to ask questions and share knowledge during all scientific sessions.

International Alzheimer’s Disease & Dementia Conference - Virtual Event | June 15-16, 2022

Dear visitors it is an honor and pleasure to invite you to our ′′International Alzheimer’s Disease& Dementia Conference′′ ?Approximately 50 million people with Alzheimer’s disease and the annual incidence of dementia diagnosis is over 9.9 million worldwide. Almost half of new dementia cases occur in Asia, foIIowed by Europe (25%),the Americas (18%) and Africa (8%). The incidence of dementia increases exponentially with age, doubling with every 6.3 year increase in age. Dementia  affects 5% of the population  older than 65 and 20-40% of those older than 85. Presentations and discussions on prevention,  neuropathology, diagnosis, management, medications, epidemiology, society and culture will help us to combat this silent epidemic. Our multidisciplinary approach offers an exclusive chance to listen alternative points of view and integrate them into their own ways as Scientists, Clinician’s, Healthcare professionals, Patients and caregivers.

International Alzheimer’s Disease & Dementia Conference - June 15-16, 2022 | Virtual Event

Dear congress visitors, it is an honor and pleasure to welcome you to Dementia 2022. Dementia is a devastating neurodegenerative condition. Though medications can alleviate some symptoms of dementia, the lack of robust biomarkers to facilitate early diagnosis means that current interventions are typically given too late to modify disease progression. Thus, accurate and timely diagnosis is key for optimal intervention. Dementia related changes likely occur decades before symptoms are observed underscoring the need for novel tools that can aid in the early identification. A better understanding of the early changes in the brain in Dementia and their relation to cognitive function using advanced imaging methods will ultimately facilitate the development of measures for early detection and progression of dementia.

4th International Conference on Neurology and Brain Disorders

Dear members of INBC 2021,
It is indeed my great honour to warmly welcome you all to the 4th International Neurology and Brain Disorders Conference, INBC 2021 and sincerely thank you for all your commitments and efforts made in preparing and presenting your innovative and valuable research and findings at this meeting. I also extend a warm welcome and gratitude to those of you who have joined us at the meeting to support your colleagues and to learn from the other presenters. INBC 2021 has expanded upon the previous years meetings in opening up several more categories for its scientific sessions, which will see this meeting to be bigger and even more exciting than its predecessors. I am sure there will be many new and exciting collaborations emerge from this meeting. I would like to take this opportunity to thank the gallant organising committee for making this meeting possible and a pleasurable experience. I wish you all great enjoyment of this meeting and much success with your presentations and forming of new collaborations. In passing, I kindly ask that you stay on where possible and support other presenters over all 3 days of this meeting, in particular those members of this meeting who will be making their international scientific presentation debut at INBC 2021.

3rd International Conference on Neurology and Brain Disorders

Dear colleagues,
It is my pleasure to welcome you all congress participants to the conference. I hope you will have interesting days. It is wide range of neurological issues that we will hear about ranging from children to adults and aspects of the influence of different drugs on the brain. We will hear about the brain development and also about the aging brain. My special interest is gut brain axis where we are beginning of understanding this complex interaction, but we still have much to learn. I hope you will have inspiring days. Very Welcome!

3rd International Conference on Neurology and Brain Disorders

Dear conference participants,
It is a great pleasure and honor for me to write this welcome address. Understanding the activity of a healthy and an altered brain is a vital focus of scientific research. Any change is a motion, and neuronal dynamics are some of the most sophisticated examples of such, positioned between basic biological and social dynamics in their complexity. Making progress in the field of neurology is thus one of the most significant global challenges of our time, with a lot of questions remaining. How can the field cooperate with fundamental sciences such as physics, mathematics, chemistry? Are there universal concepts in neuroscience similar to Newton’s Second Law? Are modern mathematical tools sufficiently developed to meet the demands of neuroscience? Are there analogous dynamics in mechanics, physics, and chemistry, which we can use to deepen our understanding of mental activity? I trust that our knowledge of the human brain will continue to evolve as we seek to answer these questions.

3rd International Conference on Neurology and Brain Disorders

Dear colleagues,
On behalf of the distinguished members of the Scientific Committee for the 3rd Edition of ‘International Conference on Neurology and
Brain Disorders and the dynamic organizing team behind this event, it is my pleasure and honour to welcome all attendees to INBC 2019. You are being sincerely thanked for your commitments and efforts in preparing and presenting your innovative and valuable research and findings at this conference. Collectively as researchers, we face an ever growingrange of challenges and pressures, as rates of and classifications of neurology and brain disorders are escalating in the bigger, stronger, faster world that we live in today. A very diverse range of distinguished speakers promise to present innovative research, interventions and therapies at this meeting that will assist in providing an antidote to an apparent global physical and mental health crisis and provide each other with opportunities for collaborations.

2nd International Conference on Neurology and Brain Disorders

Following the success of INBC 2017 at Valencia, Spain, we take pleasure to announce the second edition “2nd International Conference on Neurology and Brain Disorders” held during June 04-06, 2018 in Rome, Italy. Research in Neurodegenerative diseases, i.e. Alzheimer’s disease, Parkinson’s Disease and depression continues to grow in size and scope. For people entering such a prolific environment, acquiring an initial understanding of these diseases becomes more difficult each year. Graduate students, postdoctoral fellows, or other early-stage scientists and senior staff focusing on Alzheimer’s disease research, can take advantage of this opportunity to accelerate their knowledge immersion towards becoming an expert in this exciting field and discuss some of the latest trends in these research fields through close interaction with established leaders in the field. Workshop sessions are emphasized to open discussion between participants and lecturers, and immediate application of new knowledge. Students will participate in faculty-led exercises such as debates.

2nd Edition of International Conference on Neurology and Brain Disorders

It is indeed my great honour to have been invited by the Organizing Committee of INBC 2018 to warmly welcome all attendees to the 2nd Edition of ‘International Conference of Neurology and Brain
Disorders. INBC 2018 brings together scientists from many disciplines, who are explorers and seekers of the fundamentals realities and underlying processes that drive the biological dynamics of the human nervous system at every scale. This has had to be our first challenge and accomplishment in order for us to determine what happens when the underlying processes go wrong, leading to the establishment and incubation of neurological diseases and disorders, or how best to approach intervention for random events such as accidental lesions to the spinal cord.“With knowledge comes the responsibility of sharing it”; Albert Einstein quoted and this quote in large, underpins motives to hold and attend this conference. I am sure that like myself, you will attend this conference to not only share your new research and your knowledge discovered along the way, but to also learn and be inspired by others. I am certain that there will be some exciting collaborations formed also that will accelerate wisdom in various disciplines. On behalf of the Organising Committee, my warmest welcome, enjoyment and success for INBC 2018.

International Conference on Neurology and Brain Disorders

Dear Attendees, Presenters, Organizing Committee and Distinguished Guests,

I am delighted to be able to welcome you to this International Neurology and Brain Disorders Conference in the beautiful city of Valencia. This 2017 conference is a remarkable gathering of some of the doyens in the field of brain disease and am both humbled and honoured to play a small part. The scientific committee have worked tirelessly to present to you a unique opportunity to see and hear about the cutting-edge work being done in numerous fast moving fields. The brain is said to be the last untapped organ. This conference shows that the tap is not only opening but gushing with knowledge.

International Conference on Neurology and Brain Disorders

Dear Attendees, Presenters, Organizing Committee and Distinguished Guests,

The invitation to write the welcome message is both an honour and a privilege. Therefore, I am very grateful to the Organizing Committee of INBC 2017. All of us are ever conscious of the need to maintain a balance between classical morphology of the neurological diseases, molecular and cellular neurobiology, new therapies, and new techniques of diagnosis. I am sure that INBC 2017 will fulfil this expectation. Furthermore, the presentations and discussion will provide provocative hypotheses and suggestions for new research directions: we will honestly say at the end of the Meeting to have learned much and to feel greatly enriched. Let me conclude with a statement taken from David Hume’s “A treatise of human nature (Book 1, part IV, section VI) (1740): “ Thus we have finished our examination of the several systems of philosophy, both of the intellectual and natural world; and in our miscellaneous way of reasoning have been led into several topics; which will either illustrate and confirm some preceding part of this discourse, or prepare the way for our following opinions. ‘This now time to return to a more close examination of our subject........”.